Baillie Gifford & CO Exact Sciences Corp Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

A detailed history of Baillie Gifford & CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 1,209,501 shares of EXAS stock, worth $59.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,209,501

Previous 1,426,617 15.22%

Holding current value

$59.9 Million

Previous $60.3 Million 36.63%

% of portfolio

0.06%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$42.43 - $70.83 $9.21 Million - $15.4 Million	-217,116 Reduced 15.22%	1,209,501 $82.4 Million
Q2 2024 Jul 25, 2024	SELL	$41.33 - $74.26 $11.4 Million - $20.4 Million	-275,371 Reduced 16.18%	1,426,617 $60.3 Million
Q1 2024 May 01, 2024	SELL	$56.27 - $73.77 $116 Million - $152 Million	-2,065,067 Reduced 54.82%	1,701,988 $118 Million
Q4 2023 Jan 26, 2024	SELL	$59.06 - $75.72 $17.7 Million - $22.7 Million	-299,275 Reduced 7.36%	3,767,055 $279 Million
Q3 2023 Nov 13, 2023	SELL	$65.94 - $99.04 $33 Million - $49.6 Million	-500,751 Reduced 10.96%	4,066,330 $277 Million
Q2 2023 Jul 28, 2023	SELL	$62.68 - $95.05 $13.5 Million - $20.5 Million	-215,265 Reduced 4.5%	4,567,081 $429 Million
Q1 2023 May 03, 2023	SELL	$47.19 - $70.77 $7.03 Million - $10.5 Million	-148,916 Reduced 3.02%	4,782,346 $324 Million
Q4 2022 Jan 24, 2023	BUY	$30.35 - $53.15 $3.58 Million - $6.27 Million	118,025 Added 2.45%	4,931,262 $244 Million
Q3 2022 Oct 27, 2022	BUY	$31.97 - $49.37 $12.7 Million - $19.7 Million	398,730 Added 9.03%	4,813,237 $156 Million
Q2 2022 Aug 08, 2022	BUY	$35.61 - $76.23 $1.99 Million - $4.25 Million	55,787 Added 1.28%	4,414,507 $174 Million
Q1 2022 May 05, 2022	SELL	$57.56 - $82.54 $10.7 Million - $15.3 Million	-185,274 Reduced 4.08%	4,358,720 $305 Million
Q4 2021 Jan 20, 2022	BUY	$72.5 - $100.68 $6.63 Million - $9.21 Million	91,467 Added 2.05%	4,543,994 $354 Million
Q3 2021 Oct 19, 2021	SELL	$90.24 - $124.05 $1.23 Million - $1.69 Million	-13,600 Reduced 0.3%	4,452,527 $425 Million
Q2 2021 Aug 02, 2021	BUY	$93.66 - $139.27 $11.2 Million - $16.6 Million	119,101 Added 2.74%	4,466,127 $555 Million
Q1 2021 May 06, 2021	BUY	$116.57 - $155.01 $373 Million - $496 Million	3,197,782 Added 278.25%	4,347,026 $573 Million
Q4 2020 Feb 10, 2021	BUY	$99.61 - $142.12 $14 Million - $20 Million	140,565 Added 13.94%	1,149,244 $152 Million
Q3 2020 Nov 12, 2020	BUY	$72.92 - $102.01 $8.06 Million - $11.3 Million	110,518 Added 12.3%	1,008,679 $103 Million
Q2 2020 Aug 12, 2020	BUY	$55.75 - $92.75 $9.39 Million - $15.6 Million	168,454 Added 23.09%	898,161 $78.1 Million
Q1 2020 May 08, 2020	BUY	$37.9 - $104.44 $349,172 - $962,205	9,213 Added 1.28%	729,707 $42.3 Million
Q4 2019 Feb 10, 2020	BUY	$77.66 - $99.74 $8.04 Million - $10.3 Million	103,524 Added 16.78%	720,494 $66.6 Million
Q3 2019 Nov 07, 2019	SELL	$90.37 - $122.49 $8.54 Million - $11.6 Million	-94,462 Reduced 13.28%	616,970 $55.8 Million
Q2 2019 Aug 08, 2019	SELL	$89.51 - $118.04 $18.2 Million - $24 Million	-203,347 Reduced 22.23%	711,432 $84 Million
Q1 2019 May 01, 2019	BUY	$61.98 - $96.5 $1.91 Million - $2.98 Million	30,885 Added 3.49%	914,779 $0
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $1.11 Million - $1.63 Million	19,765 Added 2.29%	883,894 $55.8 Million
Q3 2018 Nov 13, 2018	BUY	$48.29 - $80.6 $16 Million - $26.6 Million	330,485 Added 61.93%	864,129 $68.2 Million
Q2 2018 Jul 17, 2018	BUY	$37.84 - $69.96 $6.48 Million - $12 Million	171,351 Added 47.3%	533,644 $31.9 Million
Q1 2018 May 10, 2018	BUY	$39.82 - $57.53 $3.04 Million - $4.39 Million	76,342 Added 26.7%	362,293 $14.6 Million
Q4 2017 Feb 13, 2018	BUY	$46.49 - $60.51 $1.21 Million - $1.57 Million	26,024 Added 10.01%	285,951 $15 Million
Q3 2017 Oct 20, 2017	BUY	$37.05 - $47.12 $9.63 Million - $12.2 Million	259,927	259,927 $12.2 Million

Others Institutions Holding EXAS

# of Institutions

671

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.77B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Exact Sciences Corp Transaction History